Immediate Impact
72 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
Works of Chang-Lu Hu being referenced
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chang-Lu Hu | 167 | 162 | 69 | 104 | 17 | 357 | |
| Carrie B. Marshall | 114 | 134 | 126 | 92 | 20 | 379 | |
| Armin Riecke | 89 | 103 | 59 | 144 | 24 | 338 | |
| Sören Kneif | 167 | 139 | 99 | 76 | 12 | 343 | |
| Katherine J. Blair | 62 | 125 | 54 | 135 | 17 | 377 | |
| Weiqing Han | 157 | 155 | 133 | 74 | 23 | 355 | |
| Mo‐Fa Gu | 131 | 126 | 103 | 56 | 16 | 332 | |
| Nishan H. Fernando | 124 | 256 | 140 | 83 | 13 | 385 | |
| Darren M. Kocs | 107 | 216 | 135 | 145 | 16 | 397 | |
| Ayat Salman | 98 | 119 | 37 | 66 | 23 | 392 | |
| Masaki Mori | 163 | 115 | 117 | 149 | 15 | 388 |
All Works
Loading papers...